LORI BORDELON LEA: Open Payments
NPI 1821229220 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,329 in 31 payments from 13 companies in 2025. Trend: 2023 $605 · 2024 $1,019 · 2025 $1,329
Food & beverage: $1,329
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $237 |
| Ardelyx, Inc. | 2 | $216 |
| Abbott Laboratories | 3 | $166 |
| Lilly USA, LLC | 4 | $158 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $149 |
| KYOWA KIRIN, INC. | 1 | $130 |
| PFIZER INC. | 1 | $94 |
| Insulet Corporation | 1 | $76 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: IBSRELA, FREESTYLE LIBRE 3, VRAYLAR, XIFAXAN, MOUNJARO, NURTEC ODT, Omnipod, UBRELVY.
Industry payments across LA — which companies pay providers there.
